Granulomatous vasculitis after the AstraZeneca anti-SARS-CoV-2 vaccine

Kidney Int. 2021 Sep;100(3):706-707. doi: 10.1016/j.kint.2021.06.033. Epub 2021 Jul 5.
No abstract available

Publication types

  • Letter

MeSH terms

  • COVID-19 Vaccines
  • COVID-19*
  • Humans
  • SARS-CoV-2
  • Vasculitis*

Substances

  • COVID-19 Vaccines